Adcon L
Alternative Names: Adcon-L; Adocon-L; GL-402; GT-402Latest Information Update: 23 Nov 2020
At a glance
- Originator Wright Medical Group
- Developer Wright Medical Group; Wright Medical Japan; Wright Medical Technology
- Class Organic chemicals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Epidural fibrosis; Post-surgical adhesions
Most Recent Events
- 10 Nov 2020 Wright Medical Group has been acquired by Stryker Corporation
- 14 Mar 2003 Gliatech's Adcon® Gel technology has been purchased by Wright Medical Group Inc.
- 01 Nov 2002 The US FDA is resuming scientific review of Gliatech's applications